Abstract
Somatostatin and its derivatives have been predominantly studied and succesfully used in endocrinological diseases. This article reviews the rationale of the use of somatostatin and its derivatives in ophthalmology based on current understanding of its action in the eye and summarizes previously published controlled studies and case series. The article points out future possible applications. Larger randomised controlled studies are necessary to confirm its current and future use. New ways of application could facilitate its broader use in ophthalmology.
| Original language | English |
|---|---|
| Pages (from-to) | 118-126 |
| Number of pages | 9 |
| Journal | Journal of Endocrinological Investigation |
| Volume | 28 |
| Issue number | 11 Suppl |
| Publication status | Published - 2005 |
